BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The Pharmacovigilance World 2023 conference will provide a pla tform for the participants to discuss\, share and stay updated with prese nt state of affairs in Pharmacovigilance and Drug safety\, and how it con tributes to the public health. It will also allow all its participants to interact with the experts\, discuss the various developments\, challenge s faced and innovations in the field. Our Pharmacovigilance conferences a re known for bringing the world-class leaders together to connect\, learn and network. The conference will bring-forth the participants and the re presentatives from various fields of pharmacovigilance and drug safety un der a common umbrella\, and will provide them an opportunity to network w ith various industry professionals including pharmaceuticals\, biologics\ , devices\, CROs and PV service providers.\n\nWith the augmented incidenc e of diseases\, and the non-medical use of prescription drugs\, the incid ence of drug abuse has increased enormously in the recent years\, which i s apparent with the excess documentation of adversities and drug toxiciti es. In this context\, the drug safety and pharmacovigilance has emerged a s a dynamic clinical and scientific discipline to provide adequate inform ation and ensure health safety by the joint interaction of doctors and pa tients in choosing appropriate treatment methods and drugs. However\, evi dence suggests though avoidable\, the adverse drug reactions (ADRs) to me dicines continue to be the bigger life risk. In England\, ADR was respons ible for up to 6% of hospital admissions\, carrying a mortality of 2% and costing the NHS £466 million per annum (€654 million\, US$ 602 million) in 2004. In some countries\, ADR is ranked among the top 10 leading cause s of mortality. The concept of drug safety and pharmacovigilance has evol ved considerably and is highly necessary to keep the severity of ADR unde r check. In order to prevent or to reduce harm to patients and improve pu blic health\, it is vital to develop and practice mechanisms for evaluati ng and monitoring the safety of medicines in clinical use. \; Pharmac ovigilance briefs the potential implications of such trends on the evolut ion of science. \;\n\nHowever\, these days it is confronting issues t o develop a better health care system in this global pitch. Some of the m ajor challenges include globalization\, web-based sales and information\, broader safety concerns\, public health versus pharmaceutical industry e conomic growth\, monitoring of established products\, developing and emer ging countries\, attitudes and perceptions to benefit and harm\, outcomes and impact\, etc. \;\n\nKey Highlights:\n\n\nPharmacovigilance and g lobalization\nPharmacovigilance in a pandemic world\nWomen and child heal th care medicines and pharmacovigilance\nPatient-centric approaches in PV \nPharmacovigilance legislation and regulations\nHarmonization and pharma covigilance\nAdvanced therapeutic techniques and pharmacovigilance\nPharm acovigilance and data management and eudravigilance\nPost-marketing surve illance in pharmacovigilance\nPV regulations and challenges\nBenefit-risk management strategies\n\n\nRisk management and minimization\nRisk Evalua tion and Mitigation\nAdverse drug reactions reporting\nSignal detection a nd post authorization safety\nGood Pharmacovigilance Practices\nInnovativ e approaches to drug safety\nStrategies to improve PV\nReal World Evidenc e in PV\nBig data and AI in pharmacovigilance\nPharmacovigilance Workflow s with AI &\; Automation\nOther emerging technologies in PV\n\nWho sho uld attend the conference?\n\nAttendees includes \; Chief Data Office r\, VPs\, GMs\, Directors\, Heads and Managers of\n\n\nPharmacovigilance\ nSafety &\; Risk management\nDrug safety\nPV Compliance\nSafety Survei llance\nMedical Affairs\nRegulatory Affairs\nInspection and Audit\nPharma coepidemiology\nPost-market studies\nMedical product safety assessment\nD rug Research &\; Development\nClinical Pharmacology\nMedical informati on\nContract outsourcing service providers\nHealth outcomes\nSales and Ma rketing\nPost-market studies\nMedical product safety assessment\nDrug Res earch &\; Development\nClinical Pharmacology\nMedical information\nCon tract outsourcing service providers\nHealth outcomes\nSales and Marketing \n DTEND:20231102T173000 DTSTAMP:20260512T231941Z DTSTART:20231101T083000 LOCATION:London\, London\, UK\, W8 5SP\, SEQUENCE:0 SUMMARY:The Pharmacovigilance World 2023 conference will provide a platfor m for the participants to discuss\, share and stay updated with present s tate of a... UID:adf385ff-d1a4-4cb1-892f-d71f16023cf0 END:VEVENT END:VCALENDAR